Nabriva Therapeutics is a biopharma company developing a new class of antibiotics (pleuromutilins) for the treatment of patients with serious infections caused by multi-drug resistant pathogens.

Nabriva Therapeutics – pleuromutilins against multi-drug resistant pathogens

Continue reading →